Increasing the dose intensity of chemotherapy may lower the risk of breast cancer recurrence and death

Bookmark and Share
Published: 7 Dec 2017
Views: 1423
Rating:
Save
Prof Richard Gray - University of Oxford, Oxford, UK

Prof Gray speaks at a SABCS 2017 press session about data from an EBCTCG meta-analysis study.

By increasing the dose intensity of chemotherapy by either shortening the intervals between the cycles or by sequential administration instead of concurrent administration of the drugs, reduced the risk of early-stage breast cancer recurrence and death compared with standard chemotherapy regimens.

Read the news story here.